A new issue of EuroIntervention

NEW ISSUE

Jun 3
A new issue of EuroIntervention

From perspectives on left atrial appendage occlusions or original research on the effects of ageing or diabetes and vulnerable plaque to chimney/snorkel stenting during TAV-in-TAV – there’s something for everyone in this issue of EuroIntervention...take a look.

ORIGINAL RESEARCH

Jun 3
Clinical value of HSR in stable angina
Coen K.M. Boerhout, Martijn Meuwissen et al.
This study found that the hyperaemic stenosis resistance (HSR) index more accurately identified the presence of inducible ischaemia and was an independent predictor of target vessel failure at 5-year follow-up in patients with chronic coronary syndromes.
Clinical value of HSR in stable angina

ORIGINAL ARTICLE

May 28
Ultrathin-strut versus thin-strut BP-SES healing and outcomes
Ryutaro Ikegami, Farouc A. Jaffer et al.
This study found similar early stent healing and 1-year clinical outcomes between ultrathin-strut (60 μm) and thin-strut (80 μm) biodegradable-polymer sirolimus-eluting stents, suggesting that stent strut thickness may not be the sole driver of the observed benefits of these stents.
Ultrathin-strut versus thin-strut BP-SES healing and outcomes

ORIGINAL ARTICLE

May 28
Impact of calcium morphologies on IVL efficacy
Angela McInerney, Nieves Gonzalo et al.
This content covers a wide range of cardiology interventions, including coronary, valvular, heart failure, and peripheral vascular procedures.
Impact of calcium morphologies on IVL efficacy

NEW ISSUE

May 20
Continue learning with EuroIntervention!

With the excitement of EuroPCR now in the past – and it was a wonderful moment to reconnect with colleagues and learn together – we move forward with thoughtful, original research on topics encompassing devices, techniques and, of course, the well- being of our patients.

Continue learning with EuroIntervention!

ORIGINAL RESEARCH

May 20
Short DAPT after NSTE-ACS in HBR patients
Davide Cao, Roxana Mehran et al.
In high bleeding risk patients undergoing non-complex PCI with an everolimus-eluting stent, 1-month DAPT was associated with similar ischemic risk and reduced bleeding compared to 3-month DAPT, regardless of clinical presentation.
Short DAPT after NSTE-ACS in HBR patients

EDITORIAL

May 28
Is this the end of the ultrathin-strut hypothesis?
Sripal Bangalore, Aloke V. Finn
The content discusses the evolution of stent technology, from thick to ultrathin drug-eluting stents, and the challenges in assessing the clinical outcomes of ultrathin-strut DES.
free
Receive our newsletter


Chimney/snorkel stenting

FLASHLIGHT

Jun 3
Chimney/snorkel stenting
Christopher L. Brown, Paul S. Teirstein et al.
A 92-year-old female with prior TAVI underwent TAV-in-TAV with chimney stenting to preserve coronary patency. Bench testing revealed that coronary stent cell-crossing height and second TAV placement are crucial for successful chimney stenting.
Subscribe banner

ORIGINAL RESEARCH

May 10
Primary results of the DECISION QFR RCT
Taku Asano, Hitoshi Matsuo et al.
The FAVOR III Europe Japan trial aims to randomize 2000 patients to either a QFR-guided or FFR-guided strategy to evaluate whether QFR yields non-inferior 12-month clinical outcomes compared to FFR for intermediate coronary stenosis.
Primary results of the DECISION QFR RCT

EDITORIAL

May 10
Combining QFR and SYNTAX Score II 2020 for decision making
Patrick W. Serruys, Pruthvi C. Revaiah
The content discusses the importance of a multidisciplinary Heart Team approach in decision-making between CABG and PCI for complex CAD, and the potential use of QFR parameters in predicting clinical outcomes.
free

EDITORIAL

May 10
Women and coronary artery disease: not just underrepresented and underdiagnosed, but also undertreated!
Roxana Mehran, Mauro Gitto
The article highlights the underrepresentation of women in cardiovascular clinical trials and the undertreatment of women with coronary artery disease in real-world practice, emphasizing the need for innovative strategies to include more women in trials and tailor management approaches.
Women and coronary artery disease: not just underrepresented and underdiagnosed, but also undertreated!
free

ORIGINAL RESEARCH

May 10
Outcomes by sex in the ISCHEMIA trial
Mario Gaudino, Bjorn Redfors et al.
In the ISCHEMIA trial, women with stable coronary artery disease were less likely to undergo revascularization than men, but the effect of an invasive versus conservative management strategy was similar between sexes.
Outcomes by sex in the ISCHEMIA trial

NEW ISSUE

May 10
The special EuroPCR 2024 issue
Davide Capodanno

The special EuroPCR 2024 issue with the VARC-HBR consensus document; a debate on systematic OCT use in PCI; outcomes by sex from the ISCHEMIA trial; the DECISION QFR trial; CART in contemporary CTO PCI; SAPIEN 3 Ultra RESILIA; predictors of late lumen loss after DCBs for de novo lesions; new-onset atrial fibrillation after TAVI; and more!

The special EuroPCR 2024 issue

ORIGINAL RESEARCH

May 8
AI-assisted decision-making for severe AS
Adil Salihu et al.
This study evaluated the ability of ChatGPT-4, a large language model, to assist in the decision-making process of Multidisciplinary Heart Teams for the management of severe aortic stenosis, finding a 77% agreement rate with the Heart Team's decisions.
AI-assisted decision-making for severe AS

Trending articles
314.48

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
42.95

Clinical research

10.4244/EIJ-D-23-00282 Jul 17, 2023
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve - DurAVR
Kodali SK et al
30.35

EXPERT REVIEW

10.4244/EIJ-D-17-00437 Feb 20, 2018
Catheter-based therapies in acute pulmonary embolism
Schultz J et al
free

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved